Finance

Lists
Why is 301331 down 2.38%?
Dive Deeper
301331:SHE
Enwei Pharmaceutical Co Ltd
CN¥23.41
-2.38%
(-0.57) 1D
Nov 16, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
CN¥23.95
High
CN¥23.98
Low
CN¥23.20
Mkt. cap
2.47B
Avg. vol.
3.05M
Volume
3.46M
Dividend
4.40%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
66.07
52-wk high
CN¥33.50
52-wk low
CN¥18.87
EPS
CN¥0.35
Shares outstanding
102.89M
No. of employees
2K
Open
CN¥23.95
High
CN¥23.98
Low
CN¥23.20
Mkt. cap
2.47B
Avg. vol.
3.05M
Volume
3.46M
Dividend
4.40%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
66.07
52-wk high
CN¥33.50
52-wk low
CN¥18.87
EPS
CN¥0.35
Shares outstanding
102.89M
No. of employees
2K
News stories
From web sources and news partners
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1.5K
Founded1986
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
263.92M
175.33M
199.25M
190.75M
Cost of goods sold
123.62M
77.69M
105.31M
101.04M
Cost of revenue
123.62M
77.69M
105.31M
101.04M
Research and development expenses
1.22M
1.11M
1.26M
1.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
108.50M
82.73M
90.38M
77.92M
Operating expense
115.42M
85.17M
93.84M
82.36M
Total operating expenses
239.04M
162.86M
199.15M
183.41M
Operating income
24.87M
12.47M
102.77K
7.34M
Other non operating income
-843.50K
-62.65K
-245.26K
151.92K
EBT including unusual items
20.98M
13.88M
4.07M
9.42M
EBT excluding unusual items
25.60M
13.52M
248.11K
8.41M
Income tax expense
5.62M
1.38M
553.50K
3.01M
Effective tax rate
26.77%
9.93%
13.59%
32.02%
Other operating expenses
3.57M
1.89M
2.41M
2.57M
Net income
15.36M
12.50M
3.52M
6.40M
Net profit margin
5.82%
7.13%
1.77%
3.36%
Earnings per share
-
-
-
-
Interest and investment income
1.88M
1.69M
892.61K
1.56M
Interest expense
-308.97K
-578.12K
-502.01K
-644.88K
Net interest expenses
1.57M
1.11M
390.60K
918.10K
Depreciation and amortization charges
-
-
-
-
EBITDA
36.41M
24.01M
12.01M
18.88M
Gain or loss from assets sale
138.01K
-
-2.69M
2.69M
Upcoming events
AI content may include mistakes. Learn more
Google apps